Andrew Cheng - 16 Aug 2024 Form 4 Insider Report for Akero Therapeutics, Inc. (AKRO)

Role
President and CEO, Director
Signature
Jonathan Young, Attorney-in-Fact
Issuer symbol
AKRO
Transactions as of
16 Aug 2024
Transactions value $
$15,091
Form type
4
Date filed
20 Aug 2024, 11:45
Previous filing
02 Jul 2024
Next filing
13 Sep 2024
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction AKRO Common Stock Options Exercise $15.1K +24.5K +4.21% $0.62 607K 16 Aug 2024 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction AKRO Stock Option (Right to Buy) Options Exercise $0 -24.5K -100% $0.00 0 16 Aug 2024 Common Stock 24.5K $0.62 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The options are vested and currently exercisable.